...
机译:乳腺浸润性导管癌中E-cadherin表达与常规免疫组化指标的相关性
Department of pathology, Isfahan university of medical science, Alzahra hospital, Isfahan, Iran;
Department of pathology, Isfahan university of medical science, Alzahra hospital, Isfahan, Iran;
Department of pathology, Isfahan university of medical science, Alzahra hospital, Isfahan, Iran;
Department of pathology, Isfahan university of medical science, Alzahra hospital, Isfahan, Iran;
Department of pathology, Isfahan university of medical science, Alzahra hospital, Isfahan, Iran;
Department of pathology, Isfahan university of medical science, Alzahra hospital, Isfahan, Iran;
Breast cancer; E-cadherin; immunohistochemistry;
机译:e-cadherin,n-cadherin和Snail的表达及其与临床病理变异的关系:埃及132例浸润性导管癌的免疫组织化学研究
机译:乳腺浸润性导管癌的鲁滨逊细胞学分级:与E-钙黏着蛋白和α-,β-和γ-连环蛋白表达及局部淋巴结转移相关。
机译:乳腺导管原位癌和浸润性导管癌中癌干细胞标志物CD44,CD24,VEGF和HIF-1α的临床病理相关性:基于免疫组织化学的初步研究。
机译:乳腺浸润性微乳头状癌中CD146的表达增加和微血管密度(MVD):与浸润性导管癌的比较研究(未另作说明)
机译:14-3-3 Zeta介导的上皮-间质转化(EMT)有助于ErbB2过表达导管原位癌(DCIS)演变为浸润性乳腺癌
机译:e-cadherinn-cadherin和Snail的表达及其与临床病理变异的关系:埃及132例浸润性导管癌的免疫组织化学研究
机译:具有小叶组分和MRI调查结果的E-Cadherin与P120表达与P120表达的相关性